The PD[N]ano Lab is delighted to announce that Carlie Kudary has successfully passed her Ph.D. qualifying examination in the Bioengineering Program at the University of Notre Dame, housed in the Department of Civil, Environmental Engineering, and Earth Sciences on August 20, 2026. Passing the qualifying exam is the milestone that formally marks the transition from …
Category Archive: Immunotherapy
Nov 28
Nallathamby Laboratory in the Press for Novel Approach to CAR-T Therapy
Glad to see that our work on using nanoparticle-based ON-OFF switches for CAR-T cells therapy against solid tumors is getting positive traction in the local media. Here is my interview with Kylie Veleta of Inside Indiana business on what motivates us to keep pushing forward. The website is Indiana business focused. The interview was part …
Nov 05
Dual Mode CT/Fluorescence Detectable Immunotargeted Nanoparticle Probes to Identify Self-Renewing Cancer Cells In Vivo
Statement of Purpose: The high mortality and poor prognosis for women diagnosed with ovarian cancer is mainly due to late diagnosis. Improved detection of primary tumors and recurring tumors after chemotherapy is, therefore, crucial to reduce ovarian cancer mortality and improve progression-free survival. However, current clinical screening and diagnostic imaging methods are limited by low …
NIH Funding Opportunities
- Request for Information (RFI): Opportunities to Reduce Administrative Burden in NIH Extramural Research October 15, 2026Notice NOT-OD-26-130 from the NIH Guide for Grants and Contracts
Recent Comments